PHARMACEUTICAL COMPOSITIONS COMPRISING FENTANYL FOR INTRANASAL DELIVERY

This invention provides a composition for intranasal delivery for the treatment or prevention of acute or chronic pain, which comprises an aqueous solution of (i) fentanyl or a pharmaceutically acceptable salt thereof and (ii) a pectin having a degree of esterification (DE value) of less than 30% pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CASTILE JONATHAN DAVID, LAFFERTY WILLIAM COLUMBUS IAN, SMITH ALAN, WATTS PETER JAMES
Format: Patent
Sprache:eng ; por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CASTILE JONATHAN DAVID
LAFFERTY WILLIAM COLUMBUS IAN
SMITH ALAN
WATTS PETER JAMES
description This invention provides a composition for intranasal delivery for the treatment or prevention of acute or chronic pain, which comprises an aqueous solution of (i) fentanyl or a pharmaceutically acceptable salt thereof and (ii) a pectin having a degree of esterification (DE value) of less than 30% provided that the composition is substantially free of divalent metal ions; and which, in comparison to a simple aqueous solution of fentanyl administered intranasally at the same dose, provides a peak plasma concentration of fentanyl (C max ) that is from 20 to 75% of that achieved using a simple aqueous solution of fentanyl administered intranasally at an identical fentanyl dose.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT2436375TT</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT2436375TT</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT2436375TT3</originalsourceid><addsrcrecordid>eNrjZHAP8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH09wsGc4I8gz393BXcXP1CHP0ifRTc_IMUPP1Cghz9HIOB6l1cfTzDXIMieRhY0xJzilN5oTQ3A1BLiLOHbmpBfnxqcUFicmpeakl8QIiRibGZsblpSIgxEUoA3SwtWg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITIONS COMPRISING FENTANYL FOR INTRANASAL DELIVERY</title><source>esp@cenet</source><creator>CASTILE JONATHAN DAVID ; LAFFERTY WILLIAM COLUMBUS IAN ; SMITH ALAN ; WATTS PETER JAMES</creator><creatorcontrib>CASTILE JONATHAN DAVID ; LAFFERTY WILLIAM COLUMBUS IAN ; SMITH ALAN ; WATTS PETER JAMES</creatorcontrib><description>This invention provides a composition for intranasal delivery for the treatment or prevention of acute or chronic pain, which comprises an aqueous solution of (i) fentanyl or a pharmaceutically acceptable salt thereof and (ii) a pectin having a degree of esterification (DE value) of less than 30% provided that the composition is substantially free of divalent metal ions; and which, in comparison to a simple aqueous solution of fentanyl administered intranasally at the same dose, provides a peak plasma concentration of fentanyl (C max ) that is from 20 to 75% of that achieved using a simple aqueous solution of fentanyl administered intranasally at an identical fentanyl dose.</description><language>eng ; por</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190524&amp;DB=EPODOC&amp;CC=PT&amp;NR=2436375T$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190524&amp;DB=EPODOC&amp;CC=PT&amp;NR=2436375T$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CASTILE JONATHAN DAVID</creatorcontrib><creatorcontrib>LAFFERTY WILLIAM COLUMBUS IAN</creatorcontrib><creatorcontrib>SMITH ALAN</creatorcontrib><creatorcontrib>WATTS PETER JAMES</creatorcontrib><title>PHARMACEUTICAL COMPOSITIONS COMPRISING FENTANYL FOR INTRANASAL DELIVERY</title><description>This invention provides a composition for intranasal delivery for the treatment or prevention of acute or chronic pain, which comprises an aqueous solution of (i) fentanyl or a pharmaceutically acceptable salt thereof and (ii) a pectin having a degree of esterification (DE value) of less than 30% provided that the composition is substantially free of divalent metal ions; and which, in comparison to a simple aqueous solution of fentanyl administered intranasally at the same dose, provides a peak plasma concentration of fentanyl (C max ) that is from 20 to 75% of that achieved using a simple aqueous solution of fentanyl administered intranasally at an identical fentanyl dose.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHAP8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH09wsGc4I8gz393BXcXP1CHP0ifRTc_IMUPP1Cghz9HIOB6l1cfTzDXIMieRhY0xJzilN5oTQ3A1BLiLOHbmpBfnxqcUFicmpeakl8QIiRibGZsblpSIgxEUoA3SwtWg</recordid><startdate>20190524</startdate><enddate>20190524</enddate><creator>CASTILE JONATHAN DAVID</creator><creator>LAFFERTY WILLIAM COLUMBUS IAN</creator><creator>SMITH ALAN</creator><creator>WATTS PETER JAMES</creator><scope>EVB</scope></search><sort><creationdate>20190524</creationdate><title>PHARMACEUTICAL COMPOSITIONS COMPRISING FENTANYL FOR INTRANASAL DELIVERY</title><author>CASTILE JONATHAN DAVID ; LAFFERTY WILLIAM COLUMBUS IAN ; SMITH ALAN ; WATTS PETER JAMES</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT2436375TT3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; por</language><creationdate>2019</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CASTILE JONATHAN DAVID</creatorcontrib><creatorcontrib>LAFFERTY WILLIAM COLUMBUS IAN</creatorcontrib><creatorcontrib>SMITH ALAN</creatorcontrib><creatorcontrib>WATTS PETER JAMES</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CASTILE JONATHAN DAVID</au><au>LAFFERTY WILLIAM COLUMBUS IAN</au><au>SMITH ALAN</au><au>WATTS PETER JAMES</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITIONS COMPRISING FENTANYL FOR INTRANASAL DELIVERY</title><date>2019-05-24</date><risdate>2019</risdate><abstract>This invention provides a composition for intranasal delivery for the treatment or prevention of acute or chronic pain, which comprises an aqueous solution of (i) fentanyl or a pharmaceutically acceptable salt thereof and (ii) a pectin having a degree of esterification (DE value) of less than 30% provided that the composition is substantially free of divalent metal ions; and which, in comparison to a simple aqueous solution of fentanyl administered intranasally at the same dose, provides a peak plasma concentration of fentanyl (C max ) that is from 20 to 75% of that achieved using a simple aqueous solution of fentanyl administered intranasally at an identical fentanyl dose.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; por
recordid cdi_epo_espacenet_PT2436375TT
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PHARMACEUTICAL COMPOSITIONS COMPRISING FENTANYL FOR INTRANASAL DELIVERY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T12%3A32%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CASTILE%20JONATHAN%20DAVID&rft.date=2019-05-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT2436375TT%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true